Analysis of volatile compounds in the breath of patients with inflammatory bowel diseases
Original articleGastroent Hepatol 2012; 66(2): 125-130.
Summarypdf Luděk Hrdlička, Kseniya Dryahina, Dana Ďuricová, Martin Bortlík, Naděžda Machková, Patrik Španěl, Milan LukášGuidelines forthe administration of aminosalicylates in patients with inflammatory bowel diseases
GuidelinesGastroent Hepatol 2012; 66(5): 391-400.
Summarypdf Lucie Prokopová, Dana Ďuricová, Martin Bortlík, Vladimír Zbořil, Milan LukášInflammatory bowel diseases in Karlovy Vary 2012
Congress reportsGastroent Hepatol 2012; 66(6): 425.
pdf Martin BortlíkIt's all about the money (… or about the woman)
EditorialGastroent Hepatol 2013; 67(1): 8-9.
pdf Martin BortlíkSerum zymogen glycoprotein 2 antibodies (anti-GP2) in patients with inflammatory bowel disease
Original articleGastroent Hepatol 2013; 67(1): 10-16.
Summarypdf Karin Malíčková, Dana Ďuricová, Martin Bortlík, Luděk Hrdlička, Naděžda Machková, Milan LukášCurrent opinion on the therapy of perianal fistulas in patients with Crohn's disease
Review articleGastroent Hepatol 2013; 67(1): 25-29.
Summarypdf Martin BortlíkEndsocopic treatment of Zenker´s diverticulum
Video case reportGastroent Hepatol 2013; 67(2): 132-133.
pdf Martin Bortlík, Jindřich LukášReport on endoscopic workshop ISCARE 2013
Congress reportGastroent Hepatol 2013; 67(3): 229.
pdf Martin Bortlík, Milan LukášLéčba těžké ataky ulcerózní kolitidy - komentář ke kazuistice dr. Mokré
NewsGastroent Hepatol 2013; 67(4): 317-318.
pdf Martin Bortlík